Abbott Laboratories
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Asset Breakdown FY2013
Total Assets: $42.94B
Liabilities Breakdown FY2013
Total Liabilities: $17.77B
Asset Breakdown
Total Assets: $42.94B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $3.48B | 8.1% |
| Accounts Receivable | $3.99B | 9.3% |
| Inventory | $2.69B | 6.3% |
| Property, Plant & Equipment | $5.91B | 13.8% |
| Goodwill | $9.77B | 22.8% |
| Intangible Assets | $5.74B | 13.4% |
| Other Assets | $11.37B | 26.5% |
Liabilities Breakdown
Total Liabilities: $17.77B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.03B | 5.8% |
| Long-Term Debt | $3.39B | 19.1% |
| Other Liabilities | $13.35B | 75.2% |